Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
As the Conley Lecturer for the combined International Federation of Head and Neck Oncologic Societies and the Annual Meeting of the American Head & Neck Society in July, Fojo made a cogent presentation on how the cost of cancer therapy is rapidly increasing, as is the incidence of cancer, and that this cost is being driven by the use of expensive drug therapies with marginal benefits. He argues that the use of these expensive therapies is cannibalizing time, money, and resources for marginal indications and less than impressive results and that this continued practice is reducing innovation and creativity.
Highlights. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1095. doi:10.1001/jamaoto.2013.4325
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: